Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    3876124 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
UCN-01 (7-Hydroxystaurosporine) to Treat Relapsed T-Cell Lymphomas
Conditions: Lymphoma, Large-Cell, Ki-1;   Lymphoma, T-Cell
Intervention: Drug: UCN-01 (7-hydroxystaurosporine)

Indicates status has not been verified in more than two years